Navigation Links
Royalty Pharma Posts Investor Presentation Summarizing Further Increased Offer For Elan
Date:6/10/2013

NEW YORK, June 10, 2013 /PRNewswire/ -- Royalty Pharma today posted a new investor presentation summarizing its Further Increased Offer for Elan Corporation, plc (NYSE: ELN) and urging Elan shareholders to VOTE AGAINST ALL FOUR of Elan's proposals at its upcoming Extraordinary General Meeting on June 17, 2013.  A copy of the new investor presentation is available at www.royaltypharma.com.

ADS holders who hold in street name must vote by Wednesday June 12 at 11:59 p.m. New York time.

Ordinary share owners have until 10:00 a.m. Irish Time on Saturday June 15 to vote by proxy through Computeshare, Elan's transfer agent.

The Further Increased Offer represents compelling, immediate value in the form of $13.00 in cash, plus continued upside participation through a contingent value right (CVR) worth up to $2.50 per share, potentially valuing each Elan share at up to $15.50.

Royalty Pharma reiterated its view of the Elan transactions:

  • Theravance: Elan overpaid by approximately $300-500m and the subset of Theravance royalties Elan agreed to buy are at a real risk of being cannibalized by other Theravance products that did not get included in the deal
  • AOP: Unjustifiable valuation at 17x EBITDA and 4.5x current revenue, extremely high multiples for what is essentially a drug distribution business
  • Speranza: disguised write-off vehicle for ELND-005, a failed drug that Elan has inexplicably been pushing forward, spending $143m on it through 2012
  • Share Buyback: As Glass-Lewis report says, the proposed share repurchase "lacks financial justification". Solely proposed to fend off Royalty Pharma

The consideration is not conditional on due diligence and has an acceptance t
'/>"/>

SOURCE Royalty Pharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Royalty Pharma Statement Regarding Withdrawal of Elan Lawsuit
2. Royalty Pharma Urges Elan Shareholders to Vote AGAINST ALL FOUR Elan Resolutions Today
3. Royalty Pharma Acceptances Announcement
4. Royalty Pharma Responds To Elans Tysabri Valuation
5. Royalty Pharma Response To Elans "Categorical View On Value"
6. Royalty Pharma Recommends Elan Shareholders vote "NO" on each of the Elan Resolutions at the Elan extraordinary general meeting
7. Royalty Pharma Issues Investor Presentation Highlighting The Strategic And Financial Advantages Of Its Offer To Acquire Elan For $12.50 Per Share In Cash
8. Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements
9. Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share
10. Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash
11. Selexis SA Sells Rights to Royalty Payments for More Than 15 Biologic Development Programs to Ligand Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)...  Express Scripts Holding Company (Nasdaq: ESRX ) ... Scripts stockholders of $441.1 million, or $0.60 per diluted ... Table 4, were $1.10 for the first quarter. 1 ... business models to choose from, it is increasingly clear ... America,s pharmacy benefits," stated George Paz, Chairman and Chief ...
(Date:4/28/2015)... 28, 2015  IGI Laboratories, Inc. (NYSE MKT: IG), ... generic pharmaceutical company, today announced it has submitted its ... Food and Drug Administration (FDA) of 2015, which brings ... at the FDA to twenty-four. Jason ... "We believe the ANDA filed today has an addressable ...
(Date:4/28/2015)... NUREMBERG , Germany , ... Une résolution plus rapide et plus facile des ... Même une panne temporaire des appareils ... en salle d,opération. Le Ziehm Remote Service offre ... rapides pour un temps de fonctionnement optimisé. Cette ...
Breaking Medicine Technology:Express Scripts Announces 1st Quarter Results; Announces New Credit Agreement; Narrows 2015 Guidance Range; Maintains Mid-Point 2Express Scripts Announces 1st Quarter Results; Announces New Credit Agreement; Narrows 2015 Guidance Range; Maintains Mid-Point 3Express Scripts Announces 1st Quarter Results; Announces New Credit Agreement; Narrows 2015 Guidance Range; Maintains Mid-Point 4Express Scripts Announces 1st Quarter Results; Announces New Credit Agreement; Narrows 2015 Guidance Range; Maintains Mid-Point 5Express Scripts Announces 1st Quarter Results; Announces New Credit Agreement; Narrows 2015 Guidance Range; Maintains Mid-Point 6Express Scripts Announces 1st Quarter Results; Announces New Credit Agreement; Narrows 2015 Guidance Range; Maintains Mid-Point 7Express Scripts Announces 1st Quarter Results; Announces New Credit Agreement; Narrows 2015 Guidance Range; Maintains Mid-Point 8Express Scripts Announces 1st Quarter Results; Announces New Credit Agreement; Narrows 2015 Guidance Range; Maintains Mid-Point 9Express Scripts Announces 1st Quarter Results; Announces New Credit Agreement; Narrows 2015 Guidance Range; Maintains Mid-Point 10Express Scripts Announces 1st Quarter Results; Announces New Credit Agreement; Narrows 2015 Guidance Range; Maintains Mid-Point 11Express Scripts Announces 1st Quarter Results; Announces New Credit Agreement; Narrows 2015 Guidance Range; Maintains Mid-Point 12Express Scripts Announces 1st Quarter Results; Announces New Credit Agreement; Narrows 2015 Guidance Range; Maintains Mid-Point 13Express Scripts Announces 1st Quarter Results; Announces New Credit Agreement; Narrows 2015 Guidance Range; Maintains Mid-Point 14Express Scripts Announces 1st Quarter Results; Announces New Credit Agreement; Narrows 2015 Guidance Range; Maintains Mid-Point 15Express Scripts Announces 1st Quarter Results; Announces New Credit Agreement; Narrows 2015 Guidance Range; Maintains Mid-Point 16Express Scripts Announces 1st Quarter Results; Announces New Credit Agreement; Narrows 2015 Guidance Range; Maintains Mid-Point 17Express Scripts Announces 1st Quarter Results; Announces New Credit Agreement; Narrows 2015 Guidance Range; Maintains Mid-Point 18IGI Laboratories, Inc. Announces Second ANDA Submission Of 2015 2Ziehm Imaging lance Ziehm Remote Service 2
... IsZo Capital Management LP, one of the largest minority shareholders ... ), announced today that it delivered the following letter to ... immediately from the agenda for the upcoming annual shareholders, meeting ... 2011 Board of Directors of Taro Pharmaceutical Industries ...
...  GeoVax Labs, Inc. (OTCQB/OTCBB: GOVX), an Atlanta-based biopharmaceutical firm ... Immunodeficiency Virus (HIV) infections, announced that the first patient ... for the Company,s HIV/AIDS therapeutic vaccine.  This is the ... of persons who are HIV infected. The ...
Cached Medicine Technology:IzSo Capital Writes to Taro Pharmaceutical Board Demanding that Liability Protection Management Proposals be Removed Immediately from Agenda for Annual Shareholders' Meeting 2IzSo Capital Writes to Taro Pharmaceutical Board Demanding that Liability Protection Management Proposals be Removed Immediately from Agenda for Annual Shareholders' Meeting 3IzSo Capital Writes to Taro Pharmaceutical Board Demanding that Liability Protection Management Proposals be Removed Immediately from Agenda for Annual Shareholders' Meeting 4IzSo Capital Writes to Taro Pharmaceutical Board Demanding that Liability Protection Management Proposals be Removed Immediately from Agenda for Annual Shareholders' Meeting 5GeoVax Labs' First Patient Inoculated in Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine 2GeoVax Labs' First Patient Inoculated in Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine 3
(Date:4/28/2015)... WUHAN, China (PRWEB) April 28, 2015 ... five major municipalities in China that will partner with ... to reduce smoking in a nation that produces more ... the world. , The project, China Tobacco Control Partnership-Tobacco ... whose leaders have shown willingness to support tobacco control ...
(Date:4/28/2015)... April 28, 2015 The popular all-natural ... up for their newly launched L-Style Revolution Program™, and ... and counting in just two short months. The ... and exercise plan for men and women of all ... weight loss and weight maintenance goals faster than traditional ...
(Date:4/28/2015)... (PRWEB) April 28, 2015 Brain: The ... American Museum of Natural History, will open at the ... supported by sponsorship from Saint Luke’s Health System. Coming ... City, Toronto, Granada and Milan, this one-of-a-kind exhibition brings ... and technology. , “Saint Luke’s and Museum at ...
(Date:4/28/2015)... 28, 2015 New and more ... more of manufacturers, payers, pharmacists and patients. Now ... journal, is partnering with the National Association of ... dedicated solely to this developing field to better ... growing need. , “This partnership creates a powerful ...
(Date:4/28/2015)... CA (PRWEB) April 28, 2015 ... the Journal of Molecular Imaging and Biology showed ... a 2nd generation fluorine-18 labeled small-molecule PSMA inhibitor. ... Hopkins University in Baltimore, MD by study co-author, ... initial human evaluation of [18F]DCFPyL demonstrated a number ...
Breaking Medicine News(10 mins):Health News:Georgia State Names Partner Cities For Tobacco Control Project 2Health News:Sports Nutrition Supplement Brand, Liporidex, Is Making History With Its New L-Style Revolution Diet & Exercise Program Reaching Over 10,000 Pounds Lost In Two Months 2Health News:Sports Nutrition Supplement Brand, Liporidex, Is Making History With Its New L-Style Revolution Diet & Exercise Program Reaching Over 10,000 Pounds Lost In Two Months 3Health News:Saint Luke's Health System to sponsor Brain: The Inside Story exhibition at Museum at Prairiefire 2Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 2Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 3Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 4Health News:Second Generation 18F-labeled Prostate-Specific Membrane Antigen (PSMA) Targeted Imaging Agent Found to be Highly Sensitive in Detecting Prostate Cancer 2Health News:Second Generation 18F-labeled Prostate-Specific Membrane Antigen (PSMA) Targeted Imaging Agent Found to be Highly Sensitive in Detecting Prostate Cancer 3
... 2, 2012 Combination drug therapy may be needed to ... by the Translational Genomics Research Institute (TGen) and Van Andel ... JAK2 Independent of Key Oncogenic Driver Mutation in Non-Small Cell ... the Public Library of Science (PLoS) ONE . ...
... Feb. 2 (HealthDay News) -- The sale of pet turtles ... the small reptiles are still available and continue to infect ... of the health danger, pet turtles are inappropriate pets in ... pregnant women, seniors and those with weak immune systems, according ...
... the most distinctive signs of the development of Alzheimer,s ... protein that neuroscientists call tau. In normal brains, tau ... In the cells of Alzheimer,s brains, by contrast, tau ... These tangles are considered a hallmark of the disease, ...
... Different kinds of lung cancer behave in different ways, ... University of Colorado Cancer Center study published in ... Society, different subgroups of non-small cell lung cancer (NSCLC) ... The study looked at 209 patients diagnosed with ...
... reason the prognosis for metastatic colon cancer has gone from ... Unfortunately, the drug can also carry with it debilitating neurological ... and needles in fingers and toes and can leave patients ... don,t receive the necessary dose to try to keep their ...
... -- A warning to certain types as those Super Bowl ... are more likely to eat too much in social situations, ... pressure to eat when they believe that their eating will ... Exline, a psychologist at Case Western Reserve University, said in ...
Cached Medicine News:Health News:Combination drug therapy urged to battle lung cancer 2Health News:Pet Turtles Carry Salmonella Dangers, CDC Warns 2Health News:Untangling the mysteries of Alzheimer's 2Health News:New research confirms need for lung cancer testing 2Health News:Balancing oxaliplatin dose with neurological side effects in metastatic colon cancer 2Health News:'People Pleasers' More Prone to Overeating: Study 2
... 220XiIII quickly prints labels up ... 10 ips. It is ideal ... as printing chemical drum labels, ... industry labels, banner-sized labels and ...
... Verification System, is used by hospitals ... the specific unit(s) of blood that ... It has the additional benefit of ... institution's policy and procedure for blood ...
... This system helps ensure a safe care environment ... down to the unit dose level. The automated ... track the location and handling of all items, ... eye preparations and more. This saves valuable time ...
... ensures your patients are receiving the proper ... uses the AutoPPI™ barcoded wristband to positively ... transfusion. SafeTx checks that the correct blood ... bedside paperwork and associated transcription errors. In ...
Medicine Products: